Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
2
Mar 11, 2013 11:22AM

Thanks for posting this. I have as yet received nothing from the company relative to the proxy.

Since the CEO's lack of investment in the company has been a frequent (and legit) topic, I note from the proxy that the 750K of options issued him at $.45 in September 2007 expired last September but 150K newer ones at $.10 were issued last week and appear to expire on May 4. (these options are in the money at present FWIW).

Questions: Are the other 750K completely off the table now? If so why bother to show them any longer? Is it perhaps to show that he was given a chance invest but he felt it was "too risky" and the under water options now prove his point?

Thanks for any light shed.

Share
New Message
Please login to post a reply